|
CHOP Part II- RESPONDERS |
Epilepsy/Antiepileptic drug response algorithm |
|
Case Only |
|
|
85% |
|
|
Group Health/University of Washington CRC Validation |
Colorectal Cancer (CRC) |
GH/UW |
Case, Control |
25 |
25 |
92%, 100% |
100%, 100% |
|
Northwestern University Validation |
Colorectal Cancer (CRC) |
Northwestern University |
Case, Control |
50 |
50 |
86%, 98% |
92% |
|
Harvard CRC Implementation |
Colorectal Cancer (CRC) |
Harvard Medical School |
Case, Control |
95 |
10,388 |
|
|
|
Geisinger Impl |
Colorectal Cancer (CRC) |
Geisinger |
Case, Control |
25 |
25 |
100%, 100% |
|
|
VUMC implementation |
Colorectal Cancer (CRC) |
Vanderbilt University Medical Center |
Case, Control |
|
|
|
|
|
CRC implementation-Columbia |
Colorectal Cancer (CRC) |
Columbia University |
Case, Control |
1 |
2,789 |
|
|
|
NU GWAS CRC cases and controls |
Colorectal Cancer (CRC) |
Northwestern University |
Case, Control |
|
|
|
|
|
Mayo Clinic CRC implicataion |
Colorectal Cancer (CRC) |
Mayo Clinic |
Case, Control |
|
|
|
|
|
NU eMERGEseq CRC cases and controls |
Colorectal Cancer (CRC) |
Northwestern University |
Case, Control |
|
|
|
|
|
Marshfield CRC Implementation |
Colorectal Cancer (CRC) |
Marshfield Clinic Research Institute |
Case Only |
|
|
|
|
|
KPWA/UW (primary site) implementation |
Colorectal Cancer (CRC) |
Group Health and University of Washington |
Case, Control |
|
|
|
|
|
CCHMC Primary Validation |
Migraine |
|
Case Only |
|
|
92% |
|
|
Geisinger Impl |
Migraine |
Geisinger |
Case, Control |
762 |
5,266 |
|
|
|
Harvard Migraine Implementation |
Migraine |
|
Case, Control |
647 |
5,734 |
|
|
|
Columbia - Migraine |
Migraine |
Columbia University Medical Center |
Case, Control |
37 |
2,294 |
|
|
|
Migraine--Columbia |
Migraine |
Columbia University |
Case, Control |
37 |
2,294 |
|
|
|
Demographics and HxDiseasDx Data Files |
Migraine |
KPWHRI |
Case, Control |
362 |
2,146 |
|
|
|
demog and HxDiseasDx data |
Migraine |
KPWHRI |
Case, Control |
362 |
2,146 |
|
|
|
Vanderbilt Migraine Implementation |
Migraine |
Vanderbilt |
Case, Control |
433 |
10,077 |
|
|
|
NU migraine for GWAS & PGx population |
Migraine |
|
Case, Control |
|
|
|
|
|
NU migraine for eMERGEseq population |
Migraine |
Northwestern University |
Case, Control |
|
|
|
|
|
CHOP eMERGE III |
Migraine |
CHOP |
Case, Control |
|
|
|
|
|
RA_Columbia |
Rheumatoid Arthritis (RA) |
Columbia University |
Case, Control |
8 |
2,793 |
|
|
|
RA for NU eMERGEseq only population |
Rheumatoid Arthritis (RA) |
Northwestern University |
Case, Control |
|
|
|
|
